Evidence map›Paper›PMID 36038613›Full record

ArticleSchizophrenia (Heidelberg, Germany)2022

Antipsychotics function as epigenetic age regulators in human neuroblastoma cells.

Jianbin Du, Yutaka Nakachi, Ayaka Fujii, Shinya Fujii, Miki Bundo, Kazuya Iwamoto

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Psychosocial moderators of polygenic risk scores of inflammatory biomarkers in relation to GrimAge.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  4. Article
  5. Review
  6. Subjective Overview of Accelerated Aging in Schizophrenia.International journal of environmental research and public health · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianbin Du *Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID http://orcid.org/0000-0003-1496-660X
Yutaka Nakachi *Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID http://orcid.org/0000-0003-1964-2495
Ayaka FujiiDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Shinya FujiiDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Miki BundoDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. bundo@kumamoto-u.ac.jp.
Kazuya IwamotoDepartment of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. iwamotok@kumamoto-u.ac.jp.ORCID http://orcid.org/0000-0002-1780-692X

Funding

Japan Agency for Medical Research and Development (AMED) JP20dm0107123Japan Agency for Medical Research and Development (AMED) JP21dm0207074MEXT | Japan Society for the Promotion of Science (JSPS) 17K10283MEXT | Japan Society for the Promotion of Science (JSPS) 18H02753MEXT | Japan Society for the Promotion of Science (JSPS) 18H05428MEXT | Japan Society for the Promotion of Science (JSPS) 18H05430MEXT | Japan Society for the Promotion of Science (JSPS) 18K07567MEXT | Japan Society for the Promotion of Science (JSPS) 21K07548
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36038613
PMCPMC9424249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.